Kangji Medical Privatization Wins Court Sanction

MT Newswires Live
2025/12/02

Kangji Medical (HKG:9997) cleared a key hurdle in its HK$9.25-per-share privatization after the Grand Court of the Cayman Islands sanctioned the scheme of arrangement by Knight Bidco, according to a Tuesday joint Hong Kong bourse filing.

The scheme is expected to become effective on Dec. 5, once the sanction order is registered with the Cayman registrar.

Kangji's shares will be withdrawn from listing on Dec. 9, the filing showed.

Upon completion, Kangji will become a wholly owned subsidiary of Knight Bidco.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10